时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
08:30-08:50 |
高血压与肾脏损害 |
张维忠 | 上海高血压研究所 |
Hypertension and kidney injury |
Weizhong Zhang | Shanghai Institute of Hypertension | |
08:50-09:10 |
高血压热点话题2021 |
孙英贤 | 中国医科大学附属第一医院 |
Hot topic of hypertension in 2021 |
Yingxian Sun | The First Affiliated Hospital of China Medical University | |
09:10-09:30 |
数字化转型和人工智能在高血压精准医疗中的应用 |
孙宁玲 | 北京大学人民医院 |
The application of digital transformation and artificial intelligence in hypertension precision medicine |
Ningling Sun | Peking University People's Hospital | |
09:30-09:50 |
提高我国高血压控制率的对策思考 |
赵连友 | 中国人民解放军空军军医大学第二附属医院 |
Countermeasures to improve the control rate of hypertension in China |
Lianyou Zhao | Air Force Military Medical University Tangdu Hospital | |
09:50-10:10 |
美国成人糖尿病患病率和心血管风险因素控制----20年趋势分析 |
钟文泽 | 上海交通大学 |
The morbidity of diabetes mellitus and the control of cardiovascular risk factors in American adults—Analysis of 20-year tendency |
Wenze Zhong | ||
10:10-10:30 |
上海市社区新型诊室血压测量系统建设 |
朱鼎良 | 上海市高血压研究所 |
The establishment of new office blood pressure measurement system in Shanghai community |
Dingliang Zhu |
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
10:30-10:50 |
心衰治疗的新格局 |
李建平 | 北京大学第一医院 |
The new pattern of heart failure therapy |
Jianping Li | Peking University First Hospital | |
10:50-11:10 |
慢病患者全生命周期管理——开滦研究的启示 |
吴寿岭 | 开栾总医院 |
The life-long management of patients with chronic diseases—The inspiration of Kailuan study |
Shouling Wu | Kailuan General Hospital | |
11:10-11:30 |
舒张功能障碍在高血压患者中的临床价值 |
卜培莉 | 山东大学齐鲁医院 |
The clinical value of diastolic dysfunction in patients with hypertension |
Peili Bu | Qilu Hospital of Shandong University | |
11:30-11:50 |
中青年高血压患者血压及心率的管理 |
王增武 | 中国医学科学院阜外医院 |
The blood pressure and heart rate management of mid-age and young hypertensive patients |
Zengwu Wang | Beijing Fuwai Hospital | |
11:50-12:10 |
舒张期高血压阈值与远期队列研究 |
牟建军 | 西安交通大学第一附属医院 |
The threshold value of diastolic hypertension and longitudinal cohort study |
Jianjun Mu | First Affiliated Hospital of Xi'an Jiaotong University | |
12:10-12:30 |
难治性高血压的发病机制及对策 |
姜一农 | 大连医科大学附属第一医院 |
Pathogenesis and countermeasures of resistant hypertension |
Yinong Jiang | The First Affiliated Hospital of Dalian Medical University |
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
13:30-13:50 |
心血管事件链的历史变迁 |
唐良秋 | 韶关粤北人民医院 |
Historical changes in cardiovascular events |
Liangqiu Tang | Yue Bei People’s Hospital | |
13:50-14:10 |
原发性醛固酮诊治进展 |
李萍 | 南昌大学第二附属医院 |
Progress in diagnosis and treatment of primary aldosterone |
Ping Li | The Second Affiliated Hospital of Nanchang University | |
14:10-14:30 |
高血压和相关疾病发病机制和干预策略研究 |
张运 | 山东大学齐鲁医院 |
Study on the pathogenesis and intervention strategies of hypertension and related diseases |
Yun Zhang | Qilu Hospital, Shandong University | |
14:30-14:50 |
肾动脉交感消融术,难治性高血压治疗的希望? |
曾春雨 | 中国人民解放军陆军特色医学中心 |
Renal artery sympathetic ablation, hope for the treatment of refractory hypertension? |
Chunyu Zeng | Daping Hospital, Army Medical University,Chongqing | |
14:50-15:10 |
绝经后高血压患者的血压管理:焦点与争议 |
余静 | 兰州大学第二医院 |
Hypertension with left ventricular hypertrophy: stratification and prevention and treatment |
Jing Yu | Lanzhou University Second Hospital | |
15:10-15:30 |
目标血压下降至120mmHg的获益与风险之争 |
谢良地 | 福建医科大学附属第一医院 |
Controversy over the benefits and risks of reducing the target blood pressure to 120mmHg |
Liangdi Xie | The First Hospital of Fujian Medical University |
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
15:30-15:50 |
高血压及肾脏保护临床研究新证据 |
陈晓平 | 四川大学华西医院 |
New Evidence from Clinical Research on Hypertension and Kidney Protection |
Xiaoping Chen | West China Hospital, Sichuan University | |
15:50-16:10 |
高血压的微循环改变 |
卢新政 | 江苏省人民医院(南京医科大学第一附属医院) |
Microcirculation changes in hypertension |
Xinzheng Lu | The First Affiliated Hospital of Nanjing Medical University | |
16:10-16:30 |
脂肪因子PGDFD在高血压心血管重塑中的作用机制研究 |
高平进 | 上海交通大学医学院附属瑞金医院 |
Study on the mechanism of adipokines PGDFD in cardiovascular remodeling in hypertension |
Pingjin Gao | Ruijin Hospital, Shanghai Jiaotong University | |
16:30-16:50 |
高血压患者心脏代谢与损伤机制 |
钟久昌 | 首都医科大学附属北京朝阳医院 |
Cardiac Metabolism and Injury Mechanism in Patients with Hypertension |
Jiuchang Zhong | Beijing Chaoyang Hospital, Capital Medical University | |
16:50-17:10 |
代谢组学在心血管疾病中的应用 |
王融 | 华大基因 |
Application of Metabonomics in Cardiovascular Diseases |
Rong Wang | BGI | |
17:10-17:30 |
高血压合并低钾血症的鉴别诊断要点 |
初少莉 | 上海交通大学医学院附属瑞金医院 |
Main points of differential diagnosis of hypertension complicated with hypokalemia |
Shaoli Chu | Ruijin Hospital, Medical School of Shanghai Jiaotong University |
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
18:30-18:50 |
浙江心血管防控体系的建设 |
俞蔚 | 浙江大学附属浙江医院 |
The Cardiovascular Disease Prevention and Control Program in Zhejiang Province |
Wei Yu | Zhejiang Hopital | |
18:50-19:10 |
内蒙古高血压远程管理模式探讨 |
孙刚 | 内蒙古科技大学包头医学院第一附属医院 |
Explorations of Remote Hypertension Management in the Inner Mongolia Autonomous Region |
Gang Sun | The First Affiliated Hospital of Baotou Medical College | |
19:10-19:30 |
江苏省高血压规范化管理的效果评估 |
向全永 | 江苏省疾病预防控制中心 |
Assessment of Standardized Management of Hypertension in Jiangsu Province |
Quanyong Xiang | ||
19:30-19:50 |
中国心血管一级预防指南解读 |
尹新华 | 深圳大学总医院 |
Interpretation of the Chinese Guideline for Primary Prevention of Cardiovascular Diseases |
Xinhua Yin | The First Affiliated Hospital of Harbin Medical University | |
19:50-20:10 |
基层高血压诊治的难点与策略 |
张亮清 | 山西省心血管病医院 |
Difficulties of and Solutions to Diagnosis and Treatment of Hypertension by Primary Healthcare Providers |
Liangqing Zhang | Cardiovascular Hospital of Shanxi Province | |
20:10-20:30 |
医防融合在慢性病防控中的重要地位 |
王家骥 | 广东省基层卫生协会 |
The Important Role of Combination of Treatment and Prevention in Chronic Disease Prevention and Control |
Jiaji Wang | School of Public Health, Guangzhou Medical University |